Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients

Psychiatric Bulletin

Volumn 26, Issue 11, 2002, Pages 418-420

  Harrington, Maria ^a   Lelliott, Paul ^a   Paton, Carol ^a   Konsolaki, Maria ^a   Sensky, Tom ^a   Okocha, Chike ^a  

^a ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSIONAL DISORDER; DOSE RESPONSE; DRUG MEGADOSE; ETHNIC AND RACIAL GROUPS; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MULTIPLE REGRESSION; POLYPHARMACY; PRESCRIPTION; PSYCHIATRIC DEPARTMENT; SCHIZOPHRENIA;

EID: 0036849259     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.26.11.418     Document Type: Article

References (3)

1. Department of Health (1998) A First Class Service. Quality in the New NHS. Wetherby: Department of Health.
2. Harrington, M., Lelliott, P., Paton, C., et al. (2002) The results of a multicentre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psychiatric Bulletin, 26, 414-418.
3. Lelliott, P., Paton, C., Harrington, M. et al. (2002) The influence of patient variables on polypharmacy and combined high dose of antipsychotic medication prescribed for in-patients. Psychiatric Bulletin, 26, 411-414.